Following up on Mr. Merabi’s reinstated JV division:
JV= private placement single asset
Leadership & Strategy mentors of MOG, Mr. Kambiz Merabi quote:
“EITHER INVEST IN SOMETHING THAT MAKES MONEY OR DO NOT INVEST AT ALL.”
We at the MOG have had both many good and just a few bad experiences with joint ventures. Here are a few lessons we’ve learned along the way. Said Merabi
Seeking for a JV Partner on some of our new projects, keep in mind we are always a GP in our JVs. We look for joint venture partners that have complementary idea and share our business goals and motivations.
After a somewhat rough 2015 in Wall Street, hedge fund investors like:
Bill Ackman, Larry Robbins, Mick McGuire, Nelson Peltz, are getting crushed again this year as some of their favorite stocks get walloped. As we look at the average hedge fund that invests in stocks — as opposed to debt or currencies — dropped 3.66% in the first month of the year, according to data from Hedge Fund Research.
The above money managers that are getting trounced include:
Pershing Square Capital Management, the publicly traded investment vehicle of billionaire hedgie Bill Ackman, fell 11% last month following a 20% decline last year, data from the web site shows.
Larry Robbins’ Glenview Capital, famous for picking stocks that could benefit from Obamacare, dropped 13.65% in January following a decline of 18% .Marcato International, a well-known activist fund run by Ackman protege Mick McGuire, fell 12.1% last month following a 9% loss last year, according to MOG’s research team.
Even last year’s winners had a tough time of it in January:
Trian Partners, whose Nelson Peltz made headlines fighting with DuPont last year, lost 7% in January,HSBC data showed. Last year, Trian posted gains of more than 4%.The decline follows big losses in some of the hedge fund industry’s top stocks likes:
Amazon.com Inc. (AMZN), for example, are down 25% this year. Apple Inc. (AAPL), another hedge fund favorite, is down 10% this year, while Netflix Inc. (NFLX) has dropped 27%.
Pharmaceutical stocks, which hedge funds poured into last year due to the heavy merger activity, are also taking a licking amid concerns about drug prices. Valeant Pharmaceuticals (VRX), a hedge fund favorite that hurt Ackman’s Pershing especially hard, is down 5% this year, following double-digit declines last year. Chemical giant DuPont (DD), meanwhile, is down 12% this year. Energy companies and financial stocks are also getting crushed on fears that they will get hurt by falling oil prices. One minor exception to the January doldrums appears to be Greenlight Capital, a hedge fund run by famed short-seller David Einhorn. The fund eked out a 1.3% return following a 20% decline last year, MOG LA research department’s data showed.
Establishment of a standalone division at Merabi Organization Group encompassing investments in Commercial real estate, infrastructure and related sectors “will enable us to take a more nimble approach for our CRE investment and gives us more buying power,” says Kambiz Merabi on a meeting with professional Lawyers, Doctors, Accountant who are out of stock market . “The timing just seemed right for our great company to bring back the JV,” he said 2/11/16
To schedule a MOG JOINT VENTURE introduction session to learn about our investment, please contact Fidel at 818-817-0019